Share on StockTwits

MiMedx Group (NASDAQ:MDXG) will be posting its quarterly earnings results on Tuesday, July 29th. Individual that are interested in participating in the company’s earnings conference call can do so using this link.

Shares of MiMedx Group (NASDAQ:MDXG) traded down 0.79% on Monday, hitting $6.25. The stock had a trading volume of 157,325 shares. MiMedx Group has a 1-year low of $1.81 and a 1-year high of $8.80. The stock has a 50-day moving average of $6.65 and a 200-day moving average of $6.58. The company’s market cap is $662.0 million.

On the ratings front, analysts at Needham & Company LLC initiated coverage on shares of MiMedx Group in a research note on Tuesday, July 15th. They set a “buy” rating and a $8.50 price target on the stock. Two research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and a consensus target price of $8.83.

MiMedx Group, Inc (NASDAQ:MDXG) is an integrated developer, manufacturer and marketer of regenerative biomaterial products processed from human amniotic membrane.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.